克隆型丰富的体态突变驱动了针对封闭的萨尔贝科病毒表位体的公共人类抗体的亲和力成熟
Vishal N Rao1, Iden A Sapse2, Hallie Cohn3
1Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Center for Vaccine Research and Pandemic Preparedness, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Cell reports
|August 13, 2025
概括
公共抗体对于疫苗开发至关重要. 研究人员发现,公共抗体克隆类型中的特定突变 (SHM) 增强了与保存表位素的结合,指导了更好的疫苗设计以保护病原体.
科学领域:
- 免疫学 免疫学 免疫学
- 疫苗学 疫苗学 疫苗学
- 结构生物学 结构生物学
背景情况:
- 识别保存表位的公共抗体对于有效的疫苗开发至关重要.
- 身体突变 (SHM) 是改善抗体亲和力和指导疫苗策略的关键.
- 了解公共抗体克隆类型中的SHM丰富对于设计针对病原体的疫苗至关重要.
研究的目的:
- 为了调查是否亲和力增强的SHM被选择性地丰富在公共抗体克隆类型中.
- 在具有已知和未知的表位特异性的公共抗体中识别SHM签名.
- 通过了解公众抗体中增强亲和力SHM的特征来指导疫苗设计.
主要方法:
- 使用M15,人类IGHV4-59/IGKV3-20公共抗体,作为一个模型系统.
- 在具有相同V基因但具有不同表位特异性的抗体中比较SHM特征.
- 在M15.的光链中分析了克隆型丰富突变.
主要成果:
- 在M15抗体的轻链中识别了克隆型丰富突变.
- 证明这些结合的SHM增强了与新型沙尔贝科病毒表位型的结合.
- 在连续接种疫苗后观察到对该表位的抗体反应增加.
结论:
- 增强亲和力的SHM在公共抗体中显示趋同和克隆型丰富.
- 这些发现为引导疫苗设计产生保护性公共抗体提供了洞察力.
- 在公众克隆型中选择性丰富SHM是一种增强抗原结合的机制.
相关概念视频
Hybridoma Technology
15.3K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
15.3K
Affinity and Avidity
36.6K
Overview
36.6K
Antigens Involved in Adaptive Immunity
669
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
Complete Antigens
Complete antigens possess both immunogenicity and...
669
T Cell Activation and Clonal Selection
4.6K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
4.6K


